William Creasman to Cohort Studies
This is a "connection" page, showing publications William Creasman has written about Cohort Studies.
Connection Strength
0.117
-
Hormone replacement therapy after cancers. Curr Opin Oncol. 2005 Sep; 17(5):493-9.
Score: 0.042
-
Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies. Am J Obstet Gynecol. 2003 May; 188(5):1174-6.
Score: 0.036
-
The role of racial genetic admixture with endometrial cancer outcomes: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2016 Feb; 140(2):264-9.
Score: 0.021
-
The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma. Eur J Obstet Gynecol Reprod Biol. 2008 Dec; 141(2):163-8.
Score: 0.013
-
A phase II trial of prolonged oral etoposide (VP-16) as second-line therapy for advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 1996 Oct; 63(1):101-4.
Score: 0.006